PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Asnis, Gregory M.
TI  - Higher Doses of Levomilnacipran May Benefit Patients with Severe Depression
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 20--20
VI  - 14
IP  - 8
4099  - http://mdc.sagepub.com/content/14/8/20.1.short
4100  - http://mdc.sagepub.com/content/14/8/20.1.full
AB  - This article presents a poster with results of a Phase 3 trial to evaluate the efficacy and tolerability of levomilnacipran extended-release (ER) dose in adult patients with major depressive disorder [APA 2014 (poster NR6-087); NCT00969709]. The results of the study indicated that higher doses of levomilnacipran ER may benefit some patients, including those with moderate to severe depression.